Legend Biotech annual gross margin
2020
2021
2022
2023
2024
2025
Legend Biotech Gross Margin Growth & History (LEGN)
Legend Biotech's gross margin was 61.41% for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 61.41% | −4.09 pp |
| 2024 | 2024-12-31 | 65.50% | +16.07 pp |
| 2023 | 2023-12-31 | 49.43% | +5.29 pp |
| 2022 | 2022-12-31 | 44.14% | −55.86 pp |
| 2021 | 2021-12-31 | 100.00% | 0.00 pp |
| 2020 | 2020-12-31 | 100.00% | — |
Legend Biotech quarterly gross margin
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 64.54% | +1.74 pp |
| Q1 2026 | 2026-03-31 | 42.35% | −22.02 pp |
| Q4 2025 | 2025-12-31 | 61.02% | −1.76 pp |
| Q3 2025 | 2025-09-30 | 58.41% | −8.81 pp |
| Q2 2025 | 2025-06-30 | 62.80% | −12.88 pp |
| Q1 2025 | 2025-03-31 | 64.37% | +16.61 pp |
| Q4 2024 | 2024-12-31 | 62.77% | +3.59 pp |
| Q3 2024 | 2024-09-30 | 67.22% | +12.51 pp |
| Q2 2024 | 2024-06-30 | 75.68% | +20.24 pp |
| Q1 2024 | 2024-03-31 | 47.76% | +45.77 pp |
| Q4 2023 | 2023-12-31 | 59.18% | — |
| Q3 2023 | 2023-09-30 | 54.72% | +47.77 pp |
| Q2 2023 | 2023-06-30 | 55.45% | — |
| Q1 2023 | 2023-03-31 | 1.99% | — |
| Q3 2022 | 2022-09-30 | 6.95% | — |
Legend Biotech gross margin trends
Over the last five fiscal years, Legend Biotech's gross margin decreased from 100.00% to 61.41%, a change of −38.59 percentage points. The latest reported quarter, Q2 2026, shows 64.54%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech source filings ↗